ImmunityBio And NCartes Enter Collaboration Agreement Aimed At Automating And Streamlining The Data Fulfillment Process For Clinical Trials; The Goal Of The Collaboration Is To Make This Essential Process Easier, Faster, And Less Expensive For...
ImmunityBio And NCartes Enter Collaboration Agreement Aimed At Automating And Streamlining The Data Fulfillment Process For Clinical Trials; The Goal Of The Collaboration Is To Make This Essential Process Easier, Faster, And Less Expensive For...
ImmunityBio And NCartes Enter Collaboration Agreement Aimed At Automating And Streamlining The Data Fulfillment Process For Clinical Trials; The Goal Of The Collaboration Is To Make This Essential Process Easier, Faster, And Less Expensive For ImmunityBio's Trial Investigators
ImmunityBio与nCartes达成合作协议，旨在自动化和简化临床试验的数据履行过程；合作的目标是使这一重要过程对ImmunityBio的试验研究人员更加简单、快速和经济。
ImmunityBio, Inc. (NASDAQ:IBRX), a vertically integrated biotechnology company, and nCartes, Inc., a transformational cloud software platform provider, announced a collaboration agreement aimed at automating and streamlining the data fulfillment process for clinical trials. The goal of the collaboration is to make this essential process easier, faster, and less expensive for ImmunityBio's trial investigators.
ImmunityBio, Inc.（纳斯达克：IBRX）是一家垂直整合的生物技术公司，而nCartes, Inc.是一家变革性的云软件平台提供商，两者宣布达成一项合作协议，旨在自动化和简化临床试验的数据履行过程。合作的目标是使这一重要过程对ImmunityBio的试验研究人员更加简单、快速和经济。
The vast majority of clinical trials today gather data manually at clinical research sites. The data is then entered by hand into Electronic Data Capture (EDC) systems used by clinical trial sponsors. This process is time-consuming, costly, and creates the potential for errors that can further delay trial results. This new collaboration will instead rely on using digital information available in source electronic medical record (EMR) systems to directly populate EDC systems.
目前绝大多数临床试验都是在临床研究现场手动收集数据。然后，这些数据通过手动方式输入到临床试验赞助商使用的电子数据采集（EDC）系统中。这个过程耗时、成本高，并且可能出现错误，从而进一步延误试验结果。这项新的合作将依赖使用可在源电子病历（EMR）系统中获得的数字信息，直接填充EDC系统。
